CRIHX
Price
$14.10
Change
-$0.09 (-0.63%)
Updated
Jul 24 closing price
Net Assets
537.33M
GARIX
Price
$23.81
Change
+$0.03 (+0.13%)
Updated
Jul 24 closing price
Net Assets
1.3B
Interact to see
Advertisement

CRIHX vs GARIX

CRIHX vs GARIX Comparison Chart in %
View a ticker or compare two or three
VS
CRIHX vs. GARIX commentary
Jul 28, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRIHX is a Buy and GARIX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GARIX has more cash in the bank: 1.3B vs. CRIHX (537M). GARIX pays higher dividends than CRIHX: GARIX (0.02) vs CRIHX (0.00). CRIHX was incepted earlier than GARIX: CRIHX (10 years) vs GARIX (14 years). CRIHX (1.86) is less costly to investors than GARIX (1.73). GARIX is a more actively managed with annual turnover of: 290.00 vs. CRIHX (65.00). CRIHX has a lower initial minimum investment than GARIX: CRIHX (10000) vs GARIX (100000). CRIHX annual gain was more profitable for investors over the last year : 16.92 vs. GARIX (10.41). GARIX return over 5 years is better than : 41.00 vs. CRIHX (26.12).
CRIHXGARIXCRIHX / GARIX
Total Expense Ratio1.771.52116%
Annual Report Gross Expense Ratio1.861.73108%
Fund Existence10 years14 years-
Gain YTD11.11110.899102%
Front LoadN/AN/A-
Min. Initial Investment1000010000010%
Min. Initial Investment IRAN/AN/A-
Net Assets537M1.3B41%
Annual Yield % from dividends0.000.02-
Returns for 1 year16.9210.41162%
Returns for 3 years19.4021.1492%
Returns for 5 years26.1241.0064%
Returns for 10 yearsN/A85.33-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PEQCX43.430.32
+0.74%
Putnam Large Cap Value C
MFWTX18.320.09
+0.49%
MFS Global Total Return A
RGECX11.630.01
+0.09%
Russell Inv Global Equity C
WPSZX48.880.04
+0.08%
AB Concentrated Growth Z
BCEMX33.03-0.68
-2.02%
Boston Common ESG Impact Em Mkts